These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 13866925)

  • 1. [Comparative study on the hyperbilirubinemic action of nicotinic acid and 3-pyridineacetic acid].
    BELLOMO G; RIZZO A
    Acta Vitaminol; 1961 Aug; 15():157-61. PubMed ID: 13866925
    [No Abstract]   [Full Text] [Related]  

  • 2. [Early experimental results concerning the hypocholesterolemic action of a higher homologue of nicotinic acid].
    FUMAROLA D; GIORDANO D
    Minerva Med; 1960 Apr; 51():1160-3. PubMed ID: 13825655
    [No Abstract]   [Full Text] [Related]  

  • 3. On the hyperbilirubinemic and hypersideremic action of nicotinic acid on normal subjects and on patients with some hematological disorders.
    GYDELL K
    Acta Med Scand; 1958 Sep; 162(1):9-27. PubMed ID: 13582601
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hyperbilirubinemic effect of nicotinic acid as liver function test].
    CORA D
    Arch Sci Med (Torino); 1956 Mar; 101(3):151-62. PubMed ID: 13314919
    [No Abstract]   [Full Text] [Related]  

  • 5. [Further research on the hypocholesteremic action of a higher homologue of nicotinic acid: 3-pyridineacetic acid].
    FUMAROLA D; GIORDANO D; DE RINALDIS P
    Minerva Med; 1963 Jan; 54():256-8. PubMed ID: 13960271
    [No Abstract]   [Full Text] [Related]  

  • 6. [A precis regarding the hypocholesterolemic activities of nicotinic acid and 3-pyridineacetic acid].
    ALTSCHUL R
    Minerva Med; 1963 Jul; 54():1969-71. PubMed ID: 14012352
    [No Abstract]   [Full Text] [Related]  

  • 7. [INFLUENCE OF SUBSTANCES WITH A PYRIDINE NUCLEUS ON SIDEREMIC AND BILIRUBINEMIC LEVELS].
    CALI G; PIETROPAOLO C; LOCOCO G
    Boll Soc Ital Cardiol; 1964; 9():328-33. PubMed ID: 14224916
    [No Abstract]   [Full Text] [Related]  

  • 8. 3-Pyridineacetic acid and nicotinic acid: blood levels, urinary elimination and excretion of nicotinic acid derivatives in man.
    GINOULHIAC E; TENCONI LT; CHIANCONE FM
    Nature; 1962 Mar; 193():948-9. PubMed ID: 13898750
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in bilirubinemia caused by nicotinic acid in normal and pathological conditions].
    PUGLIESE F; MARRI G; CALANDRA P
    Boll Soc Ital Biol Sper; 1961 Aug; 37():771-3. PubMed ID: 14489164
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of nicotinic acid on sideremia, bilirubinemia and total iron-binding capacity of the blood (TIBC)].
    Mikes A; Dratil-Stevanovic V
    Srp Arh Celok Lek; 1961 Sep; 89():981-9. PubMed ID: 14473683
    [No Abstract]   [Full Text] [Related]  

  • 11. The hyperbilirubinemic effect of sodium nicotinate.
    STEFANINI M
    J Lab Clin Med; 1949 Aug; 34(8):1039-48. PubMed ID: 18136206
    [No Abstract]   [Full Text] [Related]  

  • 12. On the hyperbilirubinemic and hyperferricemic action of nicotinic acid.
    GYDELL K
    Scand J Clin Lab Invest; 1958; 10(1):115. PubMed ID: 13555706
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hyperbilirubinemia caused by sodium nicotinate in icterogenic liver diseases].
    CORA D; MORISANI P
    Acta Med Patav; 1956; 16(1):107-24. PubMed ID: 13339130
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical significance of hyperbilirubinemia due to nicotinic acid.
    MARFORI L; STEFANINI M; BRAMANTE P
    Am J Med Sci; 1947 Feb; 213(2):150-2. PubMed ID: 20283824
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hyperbilirubinemia provoked by sodium nicotinate in regressive chronic liver diseases].
    CORA D
    Arch Sci Med (Torino); 1950 Sep; 90(3):222-39. PubMed ID: 14777663
    [No Abstract]   [Full Text] [Related]  

  • 16. [Various aspects of bilirubinemic curve from nicotinic acid administration in physiological pregnancy and various toxicoses of pregnancy].
    ABRESCIA N
    Monit Ostet Ginecolog; 1951; 22(1):13-21. PubMed ID: 14843017
    [No Abstract]   [Full Text] [Related]  

  • 17. [The action of nicotinic acid and 3-pyridyl-acetic acid on the mechanisms of hemostasis. Modifications of the intensity of the hemorrhage].
    FRANDOLI G
    Acta Vitaminol; 1962; 16():131-9. PubMed ID: 13959208
    [No Abstract]   [Full Text] [Related]  

  • 18. [3-Pyridylacetic acid: drug kinetics and relations with the metabolism of nicotinic acid].
    GINOULHIAC E; TENCONI LT
    Minerva Med; 1960 Apr; 51():1166-9. PubMed ID: 13850212
    [No Abstract]   [Full Text] [Related]  

  • 19. [BILIRUBINEMIA AND SIDEREMIA DURING PROLONGED TREATMENT WITH SODIUM NICOTINATE].
    CALI G; PIETROPAOLO C; FIORENTINO E
    Boll Soc Ital Cardiol; 1964; 9():339-43. PubMed ID: 14224918
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti-atherosclerotic action of vitamin A compounds, nicotinic acid, beta-pyridyl compounds and arachidonic acid].
    WEITZEL G; WAHL P; BUDDECKE E
    Hoppe Seylers Z Physiol Chem; 1962 May; 327():109-27. PubMed ID: 14005951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.